Comerica Bank’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Comerica Bank’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-25,752	Closed	-$460K	–	2309
2017 Q4	$460K	Sell	25,752 -579	-2%	-$7.13K	﹤0.01%	1957
2017 Q3	$250K	Buy	26,331 +484	+2%	+$5.43K	﹤0.01%	2107
2017 Q2	$284K	Sell	25,847 -1,418	-5%	-$14.5K	﹤0.01%	2023
2017 Q1	$275K	Buy	+27,265	New	+$316K	﹤0.01%	2045

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Comerica Bank's SCMP Position: Q1 2018 in Review

Comerica Bank sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 25,752 shares — an estimated $460K sold.

Comerica Bank first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $460K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Comerica Bank reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Comerica Bank sold 25,752 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $460K.
Comerica Bank first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
Comerica Bank's Sucampo Pharmaceuticals, Inc. position peaked at $460K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Comerica Bank's 13F filing for Q1 2018, filed 1 May 2018.